Corient Private Wealth LP Grows Stock Position in Crocs, Inc. $CROX

Key Points

• Corient Private Wealth more than doubled its Crocs position in the second quarter, increasing holdings by 107.3% to 23,832 shares valued at approximately $2.875 million. Institutional investors and hedge funds collectively own 93.44% of CROX.
• Analysts maintain a generally positive outlook, with Crocs receiving a consensus “Moderate Buy” rating and an average price target of $139.10. Recent targets range from $118 to $163.
• Crocs exceeded quarterly expectations, reporting $4.55 in earnings per share and $1.18 billion in revenue, while revenue increased 2.6% year over year. The company guided to fiscal 2026 earnings of $13.70–$14.00 per share.

Corient Private Wealth LP lifted its position in Crocs, Inc. (NASDAQ:CROX - Free Report) by 107.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,832 shares of the textile maker's stock after acquiring an additional 12,335 shares during the period. Corient Private Wealth LP's holdings in Crocs were worth $2,875,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Crocs in the second quarter worth about $561,223,000. Patient Capital Management LLC purchased a new stake in Crocs during the 2nd quarter valued at about $96,443,000. Norges Bank acquired a new stake in Crocs in the 4th quarter valued at about $67,545,000. Himalaya Capital Management LLC acquired a new stake in Crocs in the 4th quarter valued at about $53,720,000. Finally, Contrarius Group Holdings Ltd lifted its stake in Crocs by 324.1% in the 4th quarter. Contrarius Group Holdings Ltd now owns 475,011 shares of the textile maker's stock worth $40,623,000 after purchasing an additional 363,010 shares in the last quarter. 93.44% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CROX has been the subject of several recent research reports. Robert W. Baird set a $163.00 price target on Crocs in a report on Friday, July 31st. Stifel Nicolaus boosted their price objective on Crocs from $105.00 to $125.00 and gave the stock a "hold" rating in a research note on Monday, June 15th. Barclays upped their target price on Crocs from $110.00 to $118.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Monness Crespi & Hardt raised their target price on Crocs from $130.00 to $160.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Crocs in a report on Monday, June 8th. They set a "buy" rating on the stock. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $139.10.

Crocs Price Performance

Crocs stock opened at $123.69 on Tuesday. The company's 50 day simple moving average is $126.43 and its 200-day simple moving average is $112.39. The company has a market capitalization of $5.93 billion, a price-to-earnings ratio of 10.69, a price-to-earnings-growth ratio of 1.02 and a beta of 1.52. Crocs, Inc. has a 1 year low of $73.21 and a 1 year high of $141.28. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.96 and a current ratio of 1.49.

Crocs (NASDAQ:CROX - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The textile maker reported $4.55 earnings per share for the quarter, topping analysts' consensus estimates of $4.35 by $0.20. Crocs had a net margin of 14.64% and a return on equity of 47.75%. The firm had revenue of $1.18 billion during the quarter, compared to analysts' expectations of $1.15 billion. During the same quarter last year, the company posted ($8.82) EPS. The firm's quarterly revenue was up 2.6% on a year-over-year basis. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. As a group, equities research analysts expect that Crocs, Inc. will post 13.95 earnings per share for the current year.

Insider Transactions at Crocs

In other Crocs news, CEO Andrew Rees sold 19,072 shares of Crocs stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $138.91, for a total value of $2,649,291.52. Following the completion of the transaction, the chief executive officer directly owned 713,293 shares of the company's stock, valued at $99,083,530.63. The trade was a 2.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Beth Kaplan purchased 885 shares of the business's stock in a transaction on Tuesday, September 15th. The shares were acquired at an average price of $112.12 per share, for a total transaction of $99,226.20. Following the completion of the purchase, the director directly owned 15,259 shares of the company's stock, valued at approximately $1,710,839.08. This trade represents a 6.16% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 3.10% of the company's stock.

Crocs Company Profile

Crocs, Inc is a global footwear company best known for its lightweight, molded clogs made from proprietary Croslite material. The company designs, manufactures, markets and distributes casual footwear, sandals, boots, slippers and accessories under the Crocs brand, including customizable Jibbitz charms.

Founded in 2002, Crocs has expanded its product range beyond its original clog design to offer footwear for women, men and children. In 2022, the company acquired HEYDUDE, a casual footwear brand known for lightweight shoes, loafers and slip-ons.

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.